cidofovir anhydrous has been researched along with B Virus Infection in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 17 (36.17) | 18.2507 |
| 2000's | 16 (34.04) | 29.6817 |
| 2010's | 13 (27.66) | 24.3611 |
| 2020's | 1 (2.13) | 2.80 |
| Authors | Studies |
|---|---|
| Daily, SL; Frederick, SL; Harden, EA; Hartline, CB; Jefferson, G; Kern, ER; Maddry, JA; Prichard, MN; Quenelle, DC; Secrist, JA; Tiwari, KN; Whitley, RJ | 1 |
| Carter, RT; Ineck, NE; Lewin, AC; Liu, CC; Marino, ME; Mironovich, MA; Yoon, A | 1 |
| Gillet, L; Javaux, J; Neyts, J; Snoeck, R; Zeippen, C | 1 |
| Hawley, J; Lappin, M; Powell, C; Rekers, W; Veir, J; Zirofsky, D | 1 |
| Andrei, G; Coen, N; Duraffour, S; Krecmerová, M; Naesens, L; Snoeck, R; Van den Oord, J | 1 |
| Boivin, G; Piret, J | 1 |
| Black, DH; Brush, LA; Eberle, R; Maxwell, LK; Mccormack, KA; Payton, ME; Ritchey, JW; Wright, G | 1 |
| Braverman, RS; Caruso Brown, AE; Cohen, MN; Giller, R; Levin, MJ; Rooney, JF; Tong, S | 1 |
| Judd, BE; Ledbetter, EC; Mohammed, HO; Pennington, MR; Spertus, CB; Van de Walle, GR | 1 |
| Galik, PK; Givens, MD; Marley, MS; Riddell, KP; Stringfellow, DA | 1 |
| Bellacicco, AL; Buonavoglia, C; Camero, M; Crescenzo, G; Decaro, N; Martella, V; Neyts, J; Tarsitano, E; Tempesta, M | 1 |
| Baba, HA; Ballauf, A; Breddemann, A; Dohna-Schwake, C; Fiedler, M; Gerner, P; Gierenz, N; Hoyer, PF; Läer, S | 1 |
| Haudebourg, J; Mounier, N; Stingaciu, S; Sudaka, I; Ticchioni, M | 1 |
| Damania, B; Moyo, TK; Richards, KL | 1 |
| Armenise, C; Bellacicco, AL; Buonavoglia, C; Camero, M; Crescenzo, G; Marinaro, M; Tarsitano, E; Tempesta, M | 1 |
| Capobianchi, A; Foà, R; Gentile, G; Girmenia, C; Iori, AP; Mauro, FR; Micozzi, A; Torelli, GF | 1 |
| Gervais, KJ; Ledbetter, EC; Pirie, CG; Pizzirani, S | 1 |
| Bolger, GT; Bousquet, C; Cordingley, MG; Garneau, M; Kibler, P; Tremblay, F | 1 |
| Goh, CL; Tan, HH | 1 |
| Bellacicco, AL; Buonavoglia, C; Camero, M; Crescenzo, G; Neyts, J; Tempesta, M; Thiry, E; Thiry, J | 1 |
| Bellacicco, AL; Buonavoglia, C; Camero, M; Crescenzo, G; Decaro, N; Elia, G; Martella, V; Neyts, J; Tarsitano, E; Tempesta, M; Thiry, E; Thiry, J | 1 |
| Fontenelle, JP; Lappin, MR; Powell, CC; Radecki, SV; Veir, JK | 1 |
| Beadle, JR; Collins, DJ; Hartline, CB; Hostetler, KY; Kern, ER; Pettway, LR; Quenelle, DC; Wan, WB | 1 |
| Barnett, BB; Holy, A; Reist, EJ; Sidwell, RW; Smee, DF | 1 |
| De Clercq, E; Neyts, J | 2 |
| Awan, AR; Field, HJ | 1 |
| De Clercq, E | 1 |
| Balzarini, J; De Clercq, E; Naesens, L | 1 |
| Reusser, P | 1 |
| Cassady, KA; Whitley, RJ | 1 |
| De Clercq, E; Neyts, J; Pagano, JS; Raab-Traub, N; Sadler, R | 1 |
| Takahashi, K | 1 |
| Cockerell, CJ; Zabawski, EJ | 1 |
| Bolger, G; Bousquet, C; Cordingley, M; Garneau, M; Kibler, P; Lapeyre, N; Rhéaume, M | 1 |
| Agut, H; Debré, P; Gautheret-Dejean, A; Grenot, P; Huraux, JM; Manichanh, C | 1 |
| Ljungman, P | 1 |
| Lawson, CM; Lenzo, JC; Shellam, GR | 1 |
| Bowers, M | 1 |
| Lalezari, J | 1 |
| De Clercq, E; Naesens, L | 1 |
| Agbalika, F; Boulanger, E; Daniel, MT; Grollet, L; Maarek, O; Molina, JM; Oksenhendler, E; Sigaux, F | 1 |
| Andrei, G; Blaheta, RA; Cinatl, J; De Clercq, E; Doerr, HW; Kreuter, J; Michaelis, M; Neyts, J; Rabenau, HF; Snoeck, R; Vogel, JU | 1 |
| Bronson, JJ; De Boeck, H; Hitchcock, MJ; Ho, HT; Martin, JC; Woods, KL | 1 |
| Field, HJ; Gibson, JS; Slater, JD | 1 |
| Bronson, JJ; Ferrara, LM; Ghazzouli, I; Hitchcock, MJ; Ho, HT; Kern, ER; Martin, JC; Soike, KF; Woods, KL | 1 |
12 review(s) available for cidofovir anhydrous and B Virus Infection
| Article | Year |
|---|---|
Antiviral drug resistance in herpesviruses other than cytomegalovirus.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; Drug Resistance, Viral; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 3, Human; Herpesvirus 6, Human; Humans; Immunocompromised Host; Organophosphonates | 2014 |
Use of cidofovir for the treatment of HIV-negative human herpes virus-8-associated primary effusion lymphoma.
Topics: Antiviral Agents; Cidofovir; Cytosine; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Injections; Lymphoma, Primary Effusion; Organophosphonates | 2010 |
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Schedule; Epstein-Barr Virus Infections; Famciclovir; Foscarnet; Herpes Zoster; Herpesviridae Infections; Humans; Immunocompromised Host; Molluscum Contagiosum; Organ Transplantation; Organophosphonates; Papillomavirus Infections; Skin Diseases, Viral; Trifluridine; Valacyclovir; Valine | 2006 |
Antivirals for the treatment of herpesvirus infections.
Topics: Acyclovir; Antiviral Agents; Belgium; Bromodeoxyuridine; Cidofovir; Cytomegalovirus Infections; Cytosine; Ganciclovir; Guanine; Herpesviridae Infections; Humans; Organophosphonates; Organophosphorus Compounds | 1993 |
The potential of acyclic nucleoside phosphonates as broad-spectrum antiviral agents.
Topics: Adenine; Animals; Antiviral Agents; Cidofovir; Cytosine; Herpesviridae Infections; Humans; Organophosphonates; Organophosphorus Compounds; Retroviridae Infections; Stereoisomerism | 1995 |
Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae; Herpesviridae Infections; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine | 1996 |
New therapeutic approaches to the alphaherpesvirus infections.
Topics: 2-Aminopurine; Acyclovir; Alphaherpesvirinae; Antibodies, Monoclonal; Arabinofuranosyluracil; Cidofovir; Cytosine; Famciclovir; Guanine; Herpesviridae Infections; Humans; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine | 1997 |
[Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Purines; Thymidine Kinase | 1998 |
Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
Topics: Administration, Cutaneous; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Herpesviridae Infections; Humans; Injections, Intralesional; Injections, Intravenous; Molluscum Contagiosum; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Sarcoma, Kaposi; Skin Diseases, Viral; Skin Neoplasms; Tumor Virus Infections | 1998 |
Prophylaxis against herpesvirus infections in transplant recipients.
Topics: Antibiotic Prophylaxis; Antiviral Agents; Cidofovir; Cytosine; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpesviridae Infections; Humans; Immunocompromised Host; Organ Transplantation; Organophosphonates; Organophosphorus Compounds; Purines; Transplantation | 2001 |
Recent developments in herpesvirus therapy.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cidofovir; Clinical Trials as Topic; Cytosine; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae Infections; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides; Valacyclovir; Valine | 2001 |
A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; Chromosome Aberrations; Cidofovir; Cyclophosphamide; Cytosine; Doxorubicin; Drug Therapy, Combination; Etoposide; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Immunophenotyping; Interferon-alpha; Karyotyping; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large-Cell, Immunoblastic; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Prednisone; Prognosis; Remission Induction; Survival Analysis; Vincristine; Vindesine; Viral Load | 2001 |
3 trial(s) available for cidofovir anhydrous and B Virus Infection
| Article | Year |
|---|---|
Evaluation of compounded cidofovir, famciclovir, and ganciclovir for the treatment of feline herpesvirus ocular surface disease in shelter-housed cats.
Topics: Animals; Antiviral Agents; Cat Diseases; Cats; Cidofovir; Famciclovir; Ganciclovir; Herpesviridae Infections; Ophthalmic Solutions; Ulcer; Varicellovirus; Weight Gain | 2023 |
Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients.
Topics: Acute Kidney Injury; Adenovirus Infections, Human; Adolescent; Antiviral Agents; BK Virus; Child; Child, Preschool; Cidofovir; Cytomegalovirus Infections; Cytosine; Female; Hematopoietic Stem Cell Transplantation; Herpesviridae Infections; Humans; Male; Organophosphonates; Pilot Projects; Polyomavirus Infections; Viremia | 2015 |
Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats.
Topics: Administration, Topical; Animals; Antiviral Agents; Cat Diseases; Cats; Cidofovir; Conjunctivitis, Viral; Cytosine; Drug Administration Schedule; Herpesviridae; Herpesviridae Infections; Male; Organophosphonates | 2008 |
32 other study(ies) available for cidofovir anhydrous and B Virus Infection
| Article | Year |
|---|---|
Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.
Topics: Animals; Antiviral Agents; Cell Line; Cell Proliferation; Cells, Cultured; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Fluorescent Antibody Technique, Indirect; Herpesviridae; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 6, Human; Herpesvirus 8, Human; Humans; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Molecular Structure; Pyrimidine Nucleosides; Viral Proteins; Virus Replication | 2009 |
Antiviral effect of the nucleoside analogue cidofovir in the context of sexual transmission of a gammaherpesvirus in mice.
Topics: Animals; Antiviral Agents; Cidofovir; Female; Herpesviridae Infections; Male; Mice, Inbred BALB C; Nucleosides; Post-Exposure Prophylaxis; Rhadinovirus; Sexually Transmitted Diseases, Viral; Virus Latency; Virus Replication; Virus Shedding | 2018 |
Feline Herpesvirus 1 and Mycoplasma spp. Conventional PCR Assay Results From Conjunctival Samples From Cats in Shelters With Suspected Acute Ocular Infections.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Antiviral Agents; Cat Diseases; Cats; Cidofovir; Conjunctiva; Cytosine; DNA, Bacterial; DNA, Viral; Eye Infections, Bacterial; Eye Infections, Viral; Herpesviridae Infections; Mycoplasma; Mycoplasma Infections; Ointments; Ophthalmic Solutions; Organophosphonates; Oxytetracycline; Polymerase Chain Reaction; Varicellovirus | 2018 |
Evaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cells.
Topics: Animals; Antiviral Agents; Apoptosis; Blotting, Western; Cells, Cultured; Cidofovir; Cyclic AMP; Cytosine; Gammaherpesvirinae; Herpesviridae Infections; Humans; Kidney; Lymphoma, B-Cell; Mice; Mice, Inbred BALB C; NIH 3T3 Cells; Organophosphonates; Organophosphorus Compounds; Prodrugs; Tumor Virus Infections; Virus Activation; Virus Replication | 2013 |
Papiine herpesvirus 2 as a predictive model for drug sensitivity of Macacine herpesvirus 1 (monkey B virus).
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cytosine; Disease Models, Animal; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Cercopithecine; Macaca mulatta; Mice; Organophosphonates; Simplexvirus; Trifluridine; Vero Cells; Viral Plaque Assay | 2014 |
In Vitro and In Vivo Evaluation of Cidofovir as a Topical Ophthalmic Antiviral for Ocular Canine Herpesvirus-1 Infections in Dogs.
Topics: Administration, Ophthalmic; Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cytosine; Disease Models, Animal; Dog Diseases; Dogs; Herpesviridae Infections; Herpesvirus 1, Canid; Madin Darby Canine Kidney Cells; Microscopy, Confocal; Organophosphonates; Random Allocation; Vero Cells; Virus Shedding | 2015 |
Lactoferrin from bovine milk inhibits bovine herpesvirus 1 in cell culture but suppresses development of in vitro-produced bovine embryos.
Topics: Animals; Antiviral Agents; Cattle; Cells, Cultured; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Embryo Culture Techniques; Embryo, Mammalian; Embryonic Development; Female; Herpesviridae Infections; Herpesvirus 1, Bovine; Lactoferrin; Milk; Organophosphonates | 2009 |
Assessing the efficacy of cidofovir against herpesvirus-induced genital lesions in goats using different therapeutic regimens.
Topics: Animals; Antiviral Agents; Base Sequence; Cidofovir; Cytosine; Disease Models, Animal; DNA Primers; DNA, Viral; Female; Genital Diseases, Female; Goat Diseases; Goats; Herpes Genitalis; Herpesviridae Infections; Humans; Organophosphonates; Species Specificity; Vaginal Creams, Foams, and Jellies; Varicellovirus | 2008 |
Primary HHV 6 infection after liver transplantation with acute graft rejection and multi-organ failure: successful treatment with a 2.5-fold dose of cidofovir and reduction of immunosuppression.
Topics: Antiviral Agents; Child, Preschool; Cholestasis, Intrahepatic; Cidofovir; Cytosine; Female; Graft Rejection; Hepatitis; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Necrosis; Organophosphonates | 2011 |
Intracavitary cidofovir for human herpes virus-8-associated primary effusion lymphoma in an HIV-negative patient.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cidofovir; Cyclophosphamide; Cytosine; Doxorubicin; Female; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Injections; Lymphoma, Primary Effusion; Organophosphonates; Pleural Effusion; Prednisone; Vincristine | 2010 |
Cidofovir does not prevent caprine herpesvirus type-1 neural latency in goats.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; DNA, Viral; Female; Ganglia; Goats; Herpesviridae Infections; Humans; Organophosphonates; Sacrococcygeal Region; Varicellovirus; Virus Latency; Virus Shedding | 2010 |
Longitudinal analysis of human herpesvirus-8 DNA and antibodies in an Italian allogeneic stem cell transplant recipient.
Topics: Antibodies, Viral; Cidofovir; Cytosine; DNA, Viral; Encephalitis; Fatal Outcome; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Italy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Organophosphonates; Stem Cell Transplantation; Transplantation, Homologous | 2011 |
Acute primary canine herpesvirus-1 dendritic ulcerative keratitis in an adult dog.
Topics: Animals; Antiviral Agents; Cidofovir; Corneal Ulcer; Cytosine; Dog Diseases; Dogs; Herpesviridae Infections; Herpesvirus 1, Canid; Immunocompromised Host; Male; Organophosphonates | 2012 |
HPMPC therapy of MCMV-induced retinal disease in the SCID mouse measured by electroretinography, a non-invasive technique.
Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Models, Animal; Electroretinography; Eye Infections, Viral; Female; Herpesviridae Infections; Humans; Mice; Mice, SCID; Muromegalovirus; Organophosphonates; Organophosphorus Compounds; Retina; Treatment Outcome; Virus Replication | 2003 |
Cidofovir is effective against caprine herpesvirus 1 infection in goats.
Topics: Animals; Cidofovir; Cytosine; Disease Models, Animal; Goats; Herpesviridae Infections; Organophosphonates; Varicellovirus; Virus Shedding | 2007 |
Potent inhibition of genital herpesvirus infection in goats by cidofovir.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Goats; Herpes Genitalis; Herpesviridae Infections; Organophosphonates; Varicellovirus | 2007 |
Effect of oral treatment with (S)-HPMPA, HDP-(S)-HPMPA or ODE-(S)-HPMPA on replication of murine cytomegalovirus (MCMV) or human cytomegalovirus (HCMV) in animal models.
Topics: Adenine; Administration, Oral; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Herpesviridae Infections; Liver; Mice; Mice, Inbred BALB C; Mice, SCID; Muromegalovirus; Organophosphonates; Survival Analysis | 2008 |
Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
Topics: Acyclovir; Animals; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Guanine; Herpesviridae Infections; Mice; Mice, SCID; Microbial Sensitivity Tests; Muromegalovirus; Nucleosides; Nucleotides; Organophosphonates; Organophosphorus Compounds | 1995 |
New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
Topics: Adenine; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Ganciclovir; Herpesviridae Infections; Humans; Immunologic Deficiency Syndromes; Mice; Mice, SCID; Muromegalovirus; Organophosphonates; Organophosphorus Compounds; Virus Replication | 1994 |
Effects of phosphonylmethoxyalkyl derivatives studied with a murine model for abortion induced by equine herpesvirus 1.
Topics: Abortion, Spontaneous; Adenine; Animals; Antiviral Agents; Cidofovir; Cytosine; Female; Herpesviridae Infections; Herpesvirus 1, Equid; Mice; Mice, Inbred BALB C; Organophosphonates; Organophosphorus Compounds; Pregnancy; Virus Replication | 1993 |
In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents.
Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Chlorocebus aethiops; Cidofovir; Cytosine; Gammaherpesvirinae; Herpesviridae Infections; Mice; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Vero Cells; Virus Replication | 1998 |
The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice.
Topics: Adolescent; Animals; Antiviral Agents; Apoptosis; Carcinoma; Cidofovir; Cytosine; Drug Screening Assays, Antitumor; Female; Ganciclovir; Genes, p53; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Injections, Intralesional; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Organophosphonates; Organophosphorus Compounds; Tumor Virus Infections | 1998 |
Acute murine cytomegalovirus infection: a model for determining antiviral activity against CMV induced hepatitis.
Topics: Alanine Transaminase; Animals; Antiviral Agents; Aspartate Aminotransferases; Body Weight; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Female; Ganciclovir; Hepatitis, Viral, Animal; Herpesviridae Infections; Liver; Mice; Mice, Inbred BALB C; Muromegalovirus; Organophosphonates; Organophosphorus Compounds; Virus Replication | 1999 |
Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis.
Topics: Antibodies, Monoclonal; Antigens, Surface; Antigens, Viral; Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Flow Cytometry; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Humans; In Vitro Techniques; Leukocytes, Mononuclear; Organophosphonates; Organophosphorus Compounds; Reproducibility of Results | 2000 |
Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Ganciclovir; Herpesviridae Infections; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Muromegalovirus; Myocarditis; Organophosphonates; Organophosphorus Compounds | 2001 |
Herpesviruses.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Cidofovir; Complementary Therapies; Cytosine; Famciclovir; Foscarnet; Herpesviridae Infections; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine; Viral Vaccines | 1995 |
Drug-resistant herpes: cidofovir gel in limbo. Interview with Jay Lalezari, M.D. Interview by John S. James.
Topics: Administration, Topical; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytosine; Drug Approval; Drug Resistance, Microbial; Gels; Herpesviridae Infections; Organophosphonates; Organophosphorus Compounds; Treatment Outcome; United States; United States Food and Drug Administration | 1997 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Amantadine; Animals; Antiviral Agents; Cidofovir; Cytosine; Famciclovir; Foscarnet; Guanine; Herpesviridae Infections; Humans; Influenza, Human; Injections, Intravenous; Lamivudine; Organophosphonates; Organophosphorus Compounds; Rats; Ribavirin; Rimantadine; Thionucleotides; Trifluridine; Valacyclovir; Valine | 2002 |
Antiviral and immunomodulatory activity of the metal chelator ethylenediaminedisuccinic acid against cytomegalovirus in vitro and in vivo.
Topics: Adjuvants, Immunologic; Animals; Antiviral Agents; Cell Adhesion; Cell Line; Chelating Agents; Cidofovir; Cytomegalovirus; Cytosine; Drug Resistance, Microbial; Ethylenediamines; Herpesviridae Infections; Humans; Intercellular Adhesion Molecule-1; Jurkat Cells; Mice; Mice, SCID; Muromegalovirus; Organophosphonates; Organophosphorus Compounds; Succinates; Virus Replication | 2002 |
Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
Topics: Animals; Antiviral Agents; Carbon Radioisotopes; Cells, Cultured; Cidofovir; Cytosine; Herpesviridae Infections; Humans; Kinetics; Magnetic Resonance Spectroscopy; Organophosphonates; Organophosphorus Compounds; Phosphates; Phosphorus | 1992 |
The activity of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine (HPMPC) against equine herpesvirus-1 (EHV-1) in cell cultures, mice and horses.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Brain Diseases; Cidofovir; Cytosine; Drug Administration Schedule; Female; Herpesviridae Infections; Herpesvirus 1, Equid; Horse Diseases; Horses; Mice; Mice, Inbred BALB C; Organophosphonates; Organophosphorus Compounds | 1992 |
(S)-1-(3-hydroxy-2-(phosphonylmethoxy)propyl)cytosine (HPMPC): a potent antiherpesvirus agent.
Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cidofovir; Cytomegalovirus Infections; Cytosine; Herpesviridae Infections; Mice; Molecular Structure; Organophosphonates; Organophosphorus Compounds | 1990 |